Birchview Capital, LP - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q3 2023$174,128
+46.4%
209,088
+111.0%
0.15%
+66.3%
Q2 2023$118,906
+95024.8%
99,0880.0%0.09%
-9.2%
Q1 2023$125
-41.9%
99,0880.0%0.10%
-35.5%
Q4 2022$215
-100.0%
99,088
-37.7%
0.15%
-88.7%
Q3 2022$1,906,000
+43.1%
159,0880.0%1.34%
+38.5%
Q2 2022$1,332,000
+18.9%
159,088
+23.2%
0.97%
+20.2%
Q1 2022$1,120,000
-1.0%
129,088
+29.1%
0.81%
+10.6%
Q4 2021$1,131,000
+124.9%
100,000
+150.0%
0.73%
+113.2%
Q3 2021$503,000
+7.2%
40,000
+33.3%
0.34%
+0.3%
Q4 2019$469,00030,0000.34%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,513,138$19,020,0004.68%
Omega Fund Management, LLC 3,320,608$41,740,0004.68%
Ally Bridge Group (NY) LLC 1,175,000$14,770,0004.34%
Parkman Healthcare Partners LLC 786,870$9,891,0002.50%
Palo Alto Investors LP 1,772,950$22,286,0001.34%
HHLR ADVISORS, LTD. 7,420,974$93,282,0001.22%
Ikarian Capital, LLC 1,351,933$16,995,0001.20%
Boxer Capital, LLC 2,462,358$30,952,0001.08%
ACUTA CAPITAL PARTNERS, LLC 215,000$2,703,0000.95%
EMERALD ADVISERS, LLC 1,516,003$19,056,0000.69%
View complete list of GOSSAMER BIO INC shareholders